Iver P. Cooper

AV stamp icon
  • Of Counsel at Browdy and Neimark, P.L.L.C. (8 Attorneys)
  • 1625 K Street, NW, Suite 1100, Washington, DC 20006
    View Iver P. Cooper's office location
  • Peer Reviews

  • Profile Visibility [ i ]
Attorney Awards


Law Clerk to Trial Judge Joseph V. Colaianni, U.S. Court of Claims, 1977-1978. Contributing Editor, Medical Devices and Diagnostics Industry Magazine, 1984-1986. Patent Counsel, Association of the Biotechnology Companies, 1985-1989. Recipient: First Prize, Nathan Burkan Memorial Competition at Boston University, sponsored by the American Society of Composers, Authors and Publishers, 1976; Robert C, Watson Award of the American Patent Law Association, 1979; Stephen P. Ladas Award for the U.S. Trademark Association, 1979. Author: Book, Biotechnology and The Law, Clark, Boardman Co., Ltd., 1982, 1985-1989, 1991-2013; Final Report to the Office of Technology Assessment, U.S. Congress on Property Rights in Cell Lines, May 23, 1986; "Patent Problem for Chemical Researchers-The Utility Requirement After Brenner v. Manson," 18 IDEA 23-37, Spring, 1976; "Patent Protection for New Forms of Life," 38 Federal Bar Journal, 34-48, Winter, 1979; "Arzberger Under the Microscope: A Critical Reexamination of the Exclusion of Bacteria From Plant Patent Protection," 7 Rutgers Journal of Computers, Technology and the Law, 367-79, February, 1980; Mapmaking and Copyright: "The Direct Observation Rule and the Public Interest," 18 Publishing, Entertainment, Advertising and Allied Fields Law Quarterly 311-33, Winter, 1980; "Trademark Aspects of Pharmaceutical Product Design," 70 Trademark Reporter 1-46, January-February, 1980; "The Patent System and the New Biology," 8 Rutgers Journal of Computers, Technology and the Law, 1-48, 1980; "Unclean Hands and Unlawful Use in Commerce: Trademarks Adrift on the Regulatory Tide," 71 Trademark Reporter, 38-58, 1981; "Preventing Inadvertent Forfeiture of Patent Rights," 5 Medical Devices and Diagnostic Industry (MDDI), 70-72, 115, March, 1983; "U.S. Export Controls on Biotechnology," 6 Recombinant DNA Technical Bulletin, 12-18, March, 1983; "Putting New Life Into Your Medical Device Patents," 8 MDDI 58-61, October, 1986. Co-author: "Final Report to the Office of Technology Assessment, U.S. Congress on Certain Laws Affecting the International Transfer of Biotechnology," April 8, 1983; Environmental Regulation of Biotechnology, MacMillan Press, 1989.

Food and Drug Law Institute, 1978-1979. Member, Board of Editors, Biotechnology Law Reports, 1982-2000. Patent and Associate General Counsel, Association of Biotechnology Companies, 1984-1989. Advisor to the Board, U.S. Patent and Trademark Office, Biotechnology Institute, 1989-1991; Member, Association of Biotechnology Companies Patent Law Working Group, 1991-1993. Co-Chair, PTO Affairs Sub-Committee, 1992-1993.

Areas of Practice (1)

  • Biotechnology and Biomedical Patents

Education & Credentials

Contact Information:
202-628-5197  Phone
University Attended:
Massachusetts Institute of Technology, B.S. in Chemistry, 1974
Law School Attended:
Boston University, Boston, J.D., 1977; George Washington University, LL.M. in Patents and Trade Regulation, 1979
Year of First Admission:
1982, U.S. Court of Appeals for the Federal Circuit; 1976, registered to practice before U.S. Patent and Trademark Office; 1978, New York; 1978, U.S. Claims Court; 1980, District of Columbia; 1984, Virginia
District of Columbia Bar; American Intellectual Property Law Association.
Birth Information:
New York, N.Y., November 10, 1953
Payment Information:
  • Free Initial Consultation
  • Fixed Hourly Rates
  • Fixed Fees Available

Peer Reviews

  • 5.0/5.0
  • A Martindale-Hubbell Peer Rating reflects a combination of achieving a Very High General Ethical Standards rating and a Legal Ability numerical rating.

*Peer Reviews provided before April 15, 2008 are not displayed.

Washington, District of Columbia

Contact Iver P. Cooper

Required Fields

Required Fields

By clicking on the "Submit" button, you agree to the Terms of Use, Supplemental Terms and Privacy Policy. You also consent to be contacted at the phone number you provided, including by autodials, text messages and/or pre-recorded calls, from Martindale and its affiliates and from or on behalf of attorneys you request or contact through this site. Consent is not a condition of purchase.

You should not send any sensitive or confidential information through this site. Emails sent through this site do not create an attorney-client relationship and may not be treated as privileged or confidential. The lawyer or law firm you are contacting is not required to, and may choose not to, accept you as a client. The Internet is not necessarily secure and emails sent though this site could be intercepted or read by third parties.